Iboga generally refers to the whole plant material, most often the root bark of Tabernanthe iboga, a shrub native to West-Central Africa. It contains a complex mixture of alkaloids alongside tannins, cellulose, and other plant compounds. The botanical context matters: Tabernanthe iboga has long-standing ceremonial significance in Bwiti and related traditions.
Ibogaine is different: it is a single purified alkaloid associated with iboga. It can be isolated from root bark or made through semi-synthetic routes from related plant material. In research and clinical discussions, it is often described as ibogaine hydrochloride, a salt with measurable composition and dosing. A useful comparative overview from the ibogaine-versus-iboga discussion similarly separates the plant’s many constituents from the isolated molecule.
That distinction does not make either category simple. Whole iboga is tied to a cultural and ceremonial setting; purified ibogaine is commonly framed through Western medical research. Both terms can appear in conversations about addiction, trauma, and brain injury, but neither should be treated as a promise of treatment or an instruction for use.
